Effect of Rebound Thymic Hyperplasia on Survival in Chemotherapy-Treated Lung Cancer.

Deniz, Sami; Susam, Seher; Aksel, Nimet; Gayaf, Mine; Güldaval, Filiz; Erbaycu, Ahmet Emin; Yilmaz, Ufuk

Deniz, Sami; Susam, Seher; Aksel, Nimet; Gayaf, Mine; Güldaval, Filiz; Erbaycu, Ahmet Emin; Yilmaz, Ufuk.

Afiliação

Deniz S; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Susam S; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Aksel N; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Gayaf M; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Güldaval F; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Erbaycu AE; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.
Yilmaz U; Department of Chest Diseases, Health Science University, Dr Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.

Turk Thorac J ; 21(5): 303-307, 2020 Sep.

Article em En | MEDLINE | ID: mdl-33031720

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Turk Thorac J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google